Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research




News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971
John.lezcano@informa.com
pharmaintelligence.informa.com

Cipla Claims Pricing Advantage For Albuterol In US

Thu, 05/23/2019 - 4:51pm

Cipla, which expects to enter the US albuterol inhalation market later this year, believes that it has the cost competitiveness...

      Related Stories 

Targovax Pivots Towards Oncolytic Viruses

Thu, 05/23/2019 - 7:36am

Oncolytic virus-based therapies which act as immune activators will be the only candidates in the Norwegian biotech’s pipeline from now...

      Related Stories 

Finance Watch: Q1 Numbers Suggest A Brisk VC Deal Pace For Cell And Gene Therapies In 2019

Wed, 05/22/2019 - 8:17pm

An Alliance for Regenerative Medicine (ARM) report shows big Q1 numbers for venture capital and partnership deals. Also, mid-May VC...

      Related Stories 

ElevateBio Announces AlloVir As First Spoke In Its Cell And Gene Therapy Hub

Wed, 05/22/2019 - 8:10pm

ElevateBio revealed the first company to hitch up with its newly established centralized cell and gene therapy development, manufacturing and...

      Related Stories 

China Forced Tech Transfer Still A Problem, EU Firms Say

Wed, 05/22/2019 - 5:38pm

One in five European pharma companies and medical devices makers has been forced to transfer technologies in China, a fact...

      Related Stories 

Mixed Responses To BioCryst's Oral Phase III HAI Therapy, BCX7353

Wed, 05/22/2019 - 9:08am

BioCryst’s BCX7353 could be the first oral therapy to prevent hereditary angioedema attacks, but it might not work in all...

      Related Stories 

Lured By Its Discovery Platform And Pipeline, Amgen Bids For Nuevolution

Wed, 05/22/2019 - 7:27am

Amgen offered to buy its Scandinavian discovery partner for $166.8m to gain access to Nuevolution’s DNA-encoded drug discovery platform and...

      Related Stories 

Google's Verily Makes Clinical Trials Pitch With Big Pharma Pacts

Wed, 05/22/2019 - 6:41am

Verily has kept a low profile since it was set up in 2015 but deals with Novartis, Otsuka, Pfizer and...

      Related Stories 

Lupin To Draw On Efficiencies As Japan Pricing Pressures Build

Wed, 05/22/2019 - 12:27am

Pricing pressure in Japan is expected to weigh significantly on growth even in the generics segment, putting the focus on...

      Related Stories 

Chugai To Plow $1bn+ Into New Core R&D Site

Tue, 05/21/2019 - 8:35pm

Japanese firm unveils major restructuring of R&D sites in Japan through a new $1bn core lab set to open in...

      Related Stories 

Merck Buys Peloton On Eve Of IPO, Expands Kidney Cancer Portfolio

Tue, 05/21/2019 - 7:22pm

Investors in Peloton, which has the only clinical-stage HIF-2α inhibitor, will get back 3.5 times the $304m in venture capital...

      Related Stories 

Lilly Advances IL-23, Gastroenterology Ambitions With Mirikizumab In Crohn's Disease

Tue, 05/21/2019 - 2:22pm

The company reported positive Phase II results and will move its potential fourth-to-market IL-23 inhibitor into Phase III in Crohn's...

      Related Stories 

Pages